Navigation Links
Angioslide Named One of Israel's Top Ten Most Promising Startups of 2011
Date:11/7/2011

CAESAREA, Israel, November 7, 2011 /PRNewswire/ --

Angioslide, a provider of Embolic Capture Angioplasty solutions, announced today that it has been named one of Israel's top ten most promising startups of 2011. The award was presented to Angioslide during the Ernst & Young (E&Y) Journey 2011 conference, held in Tel Aviv -  one of Israel's leading technology conferences, featuring prominent technology, healthcare and cleantech companies.  

"We are proud and honored to receive this award," said Lihu Avitov, CEO of Angioslide.  "Angioslide's innovative technology enables physicians to perform intravascular interventions while simultaneously providing embolic protection without the use of additional devices.   We have an early and growing group of physicians who are integrating our products into their standard of care for treating difficult lesions in peripheral vascular disease. We are focused on providing our clients with a full range of products and expanding adoption of our products around the world."

"The Angioslide PROTEUS™ catheter is a unique and proprietary device that combines balloon angioplasty and embolic capture, "said Mike Berman, a board member of Angioslide.  "Physicians are increasingly recognizing the potential of the PROTEUS to treat complex peripheral vascular disease."

Over 18 million people suffer from peripheral artery disease in the US alone. In recent years catheter-based interventions have become the primary therapeutic approach for these patients.  With the increase in life expectancy, diabetes prevalence, and number of high-risk patients, physicians are seeking to expand the current interventional "tool box" to improve procedure outcomes. Angioslide's PROTEUS device, combining a Percutaneous Transluminal Angioplasty (PTA) balloon and embolic capture of particles in one device, addresses this need.

About Angioslide

Founded in 2005, Angioslide is a privately held medical device company that developed a unique Embolic Capture Angioplasty solution, PROTEUS™, which provides a combination of PTA balloon and embolic capture. The PROTEUS device addresses an unmet need for an easy-to-use, efficient and cost-effective embolic particle capture solution for the peripheral vascular disease market. It is the first device of its kind to receive FDA clearance for use in lower limbs. The device has also received European CE Mark approval for lower limb use and is being marketed in selected regions in Europe. Angioslide headquarters are located in Caesarea, Israel, with regional offices in Europe and the US. For more information visit our website at http://www.angioslide.com

Contact:
Shira Doron
Marketing Director
Mobile: +972-54-9011134
shirad@angioslide.com

 



'/>"/>
SOURCE Angioslide Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
4. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
7. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
8. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
9. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
10. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
11. NovaVision CEO Named Presenter at the AdvaMed 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... and biotechnology companies dedicated to collaboratively developing improved chemistry, manufacturing and control ... vendor-supported, portable online UHPLC, with robust, probe-based sampling. , Online liquid ...
(Date:12/2/2016)... --  SurePure, Inc. (OTCQB: SURP) a global leader ... concluded an agreement with Tamarack Biotics under which Tamarack ... acquire units of the Company,s patented photopurification technology with ... Concurrently with the option, SurePure has entered ... seek regulatory approvals in the United States ...
(Date:12/2/2016)... 2, 2016 /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, ... Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , ... Pharmaceutical Association (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy representatives ...
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the appointment ... of Medical Affairs.  Dr. Coleman will oversee ... company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular ... sequencing data and clinical decision support, from quality control through ... , , ...
Breaking Biology Technology:
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/14/2016)... Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), ... in challenging operating environments, announced its results for the ... a conference call to discuss these results on November ... Key Recent Accomplishments ... acquire Vislink Communication Systems. The purchase is expected to ...
Breaking Biology News(10 mins):